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Background: Clinical evidence in coronary surgery is usually derived from retrospective, single institutional series.
This may introduce significant biases in the analysis of critical issues in the treatment of these patients. In order to
avoid such methodological limitations, we planned a European multicenter, prospective study on coronary artery
bypass grafting, the E-CABG registry.
Design: The E-CABG registry is a multicenter study and its data are prospectively collected from 13 centers of
cardiac surgery in university and community hospitals located in six European countries (England, Italy, Finland,
France, Germany, Sweden). Data on major and minor immediate postoperative adverse events will be collected.
Data on late all-cause mortality, stroke, myocardial infarction and repeat revascularization will be collected during a
10-year follow-up period. These investigators provided a score from 0 to 10 for any major postoperative adverse
events and their rounded medians were used to stratify the severity of these complications in four grades. The sum
of these scores for each complication/intervention occurring after coronary artery bypass grafting will be used as an
additive score for further stratification of the prognostic importance of these events.
Discussion: The E-CABG registry is expected to provide valuable data for identification of risk factors and treatment
strategies associated with suboptimal outcome. These information may improve the safety and durability of coronary
artery bypass grafting. The proposed classification of postoperative complications may become a valuable research tool
to stratify the impact of such complications on the outcome of these patients and evaluate the burden of resources
needed for their treatment.
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Myocardial revascularization is the most common
cardiac surgical procedure. Although the efficacy and
long-term durability of coronary artery bypass grafting
(CABG) over percutaneous coronary intervention (PCI)
has been largely proved in a number of subsets of pa-
tients [1, 2], PCI along with its related technological ad-
vances has slowly become the most common invasive
treatment method for coronary artery disease. The min-
imally invasive nature and the low risk of immediate ad-
verse events are strong arguments in favor of PCI.
However, the current durability of PCI is most likely in-
ferior to that of CABG, particularly in patients with mul-
tivessel disease [1, 2], diabetes [2, 3] and renal failure [4].
Contrary to PCI, advancements in coronary surgery
during the last decade have been slow and limited to im-
provements in perfusion and anesthesiological methods.
Furthermore, clinical evidence in CABG is usually de-
rived from retrospective and single institutional series
and this may introduce significant biases in the analysis
of critical issues in the treatment of these patients.
However, since CABG is a major surgical procedure as-
sociated with postoperative mortality and significant
morbidity, there is a need of improvements in the treat-
ment of patients undergoing coronary surgery in order
to reduce the risk of early and late adverse events. Pro-
spective analyses of the impact of baseline risk factors,
operative techniques, perioperative treatment methods
and secondary prevention strategies on the outcome of
patients undergoing surgical revascularization of the
myocardium are expected to provide valuable and reli-
able information to improve the safety and durability of
CABG.
Rationale of the study
Improvements in the surgical treatment of cardiac dis-
eases are possible only when implementation of current
methods and development of new methods are based on
the solid ground of large and reliable clinical data [5].
Knowledge on these issues can be generated by clinical
prospective registries. The rationale of this European
multicenter study on patients undergoing isolated CABG
(E-CABG) is therefore to collect in a prospective fashion
current data on baseline characteristics, operative and
anesthesiological methods and postoperative outcome of
patients undergoing CABG in several European centers
of cardiac surgery.
Prospective clinical registries have a relevant role in
clinical research as they differ from randomized clinical
trials in many aspects. They require less resources and
are not narrowly focused on specific subsets of patients,
but rather provide data on general patient populations
with limited exclusion criteria. Importantly, clinical
registries may provide data on long-term outcome thatexceed the study window of a trial [5]. Clinical findings
of registries assume even more significance when includ-
ing study populations from different geographic areas
with heterogeneous referral pathways, baseline clinical
characteristics and perioperative treatment strategies.
The E-CABG has been planned to provide data with
well-defined definition criteria and this paper is a sum-
mary of baseline, operative and postoperative variables.
In particular, these investigators propose a grading sys-
tem to stratify the severity of postoperative complica-
tions in patients undergoing adult cardiac surgery. This
study is registered in Clinicaltrials.gov with the number
NCT02319083.
Methods
Setting, design, study population, patient recruitment
and study period
The E-CABG is an observational registry study and its
data are prospectively collected consecutively from 13
centers of cardiac surgery of either university or commu-
nity hospitals located in six European countries
(England, Finland, France, Germany and Italy) (Table 1).
Patients aged > 18 years undergoing isolated primary or
redo CABG for stable coronary artery disease or acute
coronary syndrome are eligible for inclusion in this pro-
spective registry. Patients undergoing any other major
cardiac surgery procedure will be excluded from this
registry. However, patients who undergo CABG associated
with Maze will be included in this registry. Patients are re-
cruited in a consecutive series from each institution and
their data collected in a specifically created Access-
datasheet. The minimum recruitment period is 12 months
(January 1 - December 31, 2015). Patients will be followed
up after surgery for the following 10 years.
Data management and monitoring
Data will be collected in to a dedicated Access datasheet
with predefined variables. Data including patients’ codes
are stored in institutional network and secured by access
code. Each Steering Committee Member is in charge for
checking the quality and validity of her/his institution’s
dataset. Auditing of the dataset will be performed every
six months at institutional level by checking the data of
10 % of patients. Data without any patient identification
code will be submitted to the principal investigator for
further data checking and merging. The merged and
checked dataset will be available to all E-CABG investi-
gators for subanalyses.
Statistical methods
Continuous variables will be reported as mean and
standard deviation or median and interquartile range as
needed. Dichotomous and nominal variables will be re-
ported as counts and percentages. Missing data will not
Table 1 Participating centers and steering committee members of the E-CABG multicenter trial
Participating centers Steering Committee Member Other Investigators
1 Department of Surgery, Oulu University Hospital, Oulu, Finland F. Biancari, Principal investigator T. Juvonen
E.M. Kinnunen
2 Department of Cardiac Surgery, Verona University Hospital, Verona, Italy F. Onorati G. Faggian
3 Division of Cardiac Surgery, Ospedali Riuniti di Trieste, Trieste, Italy G. Gatti A. Pappalardo
L. Maschietto
4 Cardiac Surgery Unit, Ferrarotto Hospital, University of Catania, Catania, Italy C. Mignosa A.S. Rubino
5 Department of Cardiac Surgery, Klinikum Nürnberg, Paracelsus Medical University,
Nuremberg, Germany
G. Santarpino T. Fischlein
6 Department of Cardiac Surgery, Leicester University Hospital, Leicester, UK G. Mariscalco G. Murphy
N. Masala
7 Department of Thoracic and Cardio-Vascular Surgery, University Hospital Jean
Minjoz, Besançon, France
A. Perrotti S. Chocron
8 Department of Molecular Medicine and Surgery, Department of Cardiothoracic
Surgery and Anesthesiology, Karolinska Institutet, Karolinska University Hospital,
Stockholm, Sweden
P. Svenarud M. Dalén
9 Unit of Cardiac Surgery, Department of Cardiosciences, Hospital S. Camillo-Forlanini,
Rome, Italy
F. Musumeci R. Gherli
10 Division of Cardiothoracic and Vascular Surgery, Pontchaillou University Hospital,
Rennes, France
V.G. Ruggieri H. Corbineau
J.P. Verhoye
11 Department of Cardiac Surgery, St. Anna Hospital, Catanzaro, Italy D. Maselli C. Dominici
S. Nardella
12 Division of Cardiac Surgery, Department of Cardiothoracic Sciences, Second
University of Naples, Naples, Italy
M. De Feo A. Della Corte
C. Bancone
13 Division of Cardiac Surgery, University of Parma, Parma, Italy T. Gherli F. Nicolini
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the Mann–Whitney U test, Student’s t-test, Kruskall-
Wallis test, Wilcoxon test, Fisher exact test, Chi-square
test and Kaplan-Meier test. Multivariable analyses will be
performed using logistic, classification tree, linear and or-
dinal regression methods as well as the Cox-proportional
hazards method. Significant differences between study
groups will be adjusted by using propensity score as covar-
iate or one-to-one propensity score matching. Matching
will be performed using a caliper width of 0.2 of the stand-
ard deviation of logit of the propensity score. Multiple
propensity score adjusted analysis will be performed in
case of multiple study groups. A Bayesian hierarchical ap-
proach will be used in case of significant between-centers
variability.
Immediate and late outcome end-points
The primary outcome end-points will be defined accord-
ing to the issue investigated in each study. The main im-
mediate outcome end-points of studies from the E-
CABG registry are: 1) In-hospital mortality and 30-day
mortality, 2) stroke, 3) prolonged use of inotropes, 4)
postoperative need of intra-aortic balloon pump (IABP)
or extracorporeal mechanical oxygenation (ECMO), 5)
immediate repeat revascularization, 6) wound infectionand mediastinitis, 7) blood losses and use of blood prod-
ucts, 8) nadir hematocrit, 9) use of prothrombotics, 10)
resternotomy for bleeding, 11) atrial fibrillation, 12)
acute kidney injury and need of renal replacement ther-
apy, 13) type V myocardial infarction, 14) pericardial ef-
fusion requiring treatment, 15) postoperative use of
antibiotics, 16) delirium requiring drug treatment, 17)
length of stay in the intensive care unit, and 18) length
of in-hospital stay. The late outcome end-points of stud-
ies from the E-CABG registry are: 1) all-cause mortality,
2) cardiovascular mortality, 3) stroke, 4) myocardial in-
farction, 5) repeat revascularization and 6) a combined
outcome end-point including any of these late adverse
events. These end-points and their definition criteria are
described in details in the following paragraphs of this
article.Dissemination policy
The research findings originating from data of the E-
CABG registry will be disseminated in the scientific
community by presenting the results of these studies in
international congresses and publishing them in peer-
review international journals in the fields of cardiac
surgery and cardiology.
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The data collection, analysis and writing process will be
monitored by the Steering Committee of the E-CABG
study. This Steering Committee is formed by a Principal
Investigator and a Representative from each of the par-
ticipating center. Participating centers and investigators
are listed in Table 1. The Members of the Steering Com-
mittee will take the responsibility for the progress of
data collection and its quality through local audit. The
Steering Committee will evaluate any study proposal and
accept/reject it by voting after having reviewed the study
plan and discussed on its feasibility.
Authorship and the right to use of the registry data
Investigators will be eligible for authorship only if they
contributed substantially to study planning, data collec-
tion, data analysis and interpretation, writing and critical
revision of the manuscripts. In view of the major efforts
that each center will face during data collection, one to
three authors per each center will be included as main
authors of each study performed using the E-CABG
registry data. Members of the Steering Committee will
decide about any co-authorship from her/his center. The
researcher who plans the sub-study, performs the ana-
lysis and writes the article will have full right to be the
first author of the study. The principal investigator will
finalize the database and will guarantee that each Steer-
ing Committee Member will have a copy of the overall
database as well as of any database created for sub-
analyses.
Research ethics approval
The study has been approved by the local Institutional
Review Board or Hospital Chief according to national
guidelines for approval of registry studies. Patients’ in-
formed consent is collected in institutions where it is
mandatory.
Schedule
Collection of baseline, operative and immediate postop-
erative outcome data has started on January 2015 and
will end not before December 2015 with a minimum
follow-up of 30-days. Follow-up data will be collected
during January of each year for ten years. The first ana-
lyses of this dataset are expected on July 2015.
Baseline characteristics and operative data: definition
criteria
Units of measurements
Units of measurements are likely to differ between cen-
ters. In order to avoid any problem during data merging
and analysis, laboratory data will be collected according
to the suggested units of measurement.Laboratory parameters
Baseline levels of hemoglobin, hematocrit, creatinine,
platelets, blood glucose, HbA1c, C-reactive protein, TT-
INR and platelets will be collected. Nadir hemoglobin
and hematocrit levels as well as highest level of serum
creatinine will be recorded as well.
Preoperative heart rate and blood pressure
These parameters are obtained in the operating room
before anesthesia induction.
Preoperative drug treatment
Data on all antithrombotic drugs administered before
surgery will be collected. The date of pause of drug
treatment refers to the last day the patient received the
drug.
Data on any oral or intravenous antibiotics adminis-
tered preoperatively without prophylaxis purpose, i.e. for
any preoperative infectious condition, will be collected.
Preoperative TIA
Transient ischemic attack refers to any preoperative
focal or global neurological syndrome caused by ische-
mia or hemorrhage resolving within 24 h.
Preoperative stroke
Any preoperative focal or global neurological syndrome
caused by ischemia or hemorrhage not resolving within
24 h.
Poor mobility
Severe impairment of mobility secondary to musculo-
skeletal or neurological dysfunction.
Extracardiac arteriopathy
One or more of the following: claudication, carotid oc-
clusion or >50 % stenosis, amputation for arterial dis-
ease, previous or planned intervention on the abdominal
aorta, limb arteries or carotids.
Diabetes
Diabetes requiring diet, oral or insulin treatment.
Hypertension
Arterial blood pressure > 140/90 mmHg or anti-
hypertensive treatment.
Renal failure
Renal failure will be classified according to the estimated
glomerular filtration rate (eGFR) calculated using the
Modification of Diet in Renal Disease Study Group
modified formula [6]. eGFR for calculation of the
EuroSCORE II [7] will be estimated using the Cockcroft-
Gault formula [8] according to the criteria of this risk
Table 3 New York Heart Association functional classes
Classes Definition
I Cardiac disease, but no symptoms and no limitation in ordinary
physical activity, e.g. no shortness of breath when walking,
climbing stairs etc.
II Mild symptoms (mild shortness of breath and/or angina) and
slight limitation during ordinary activity.
III Marked limitation in activity due to symptoms, even during
less-than-ordinary activity, e.g. walking short distances
(20–100 m). 2Comfortable only at rest
IV Severe limitations. Experiences symptoms even while at rest.
Mostly bedbound patients
Table 4 Urgency classes of the procedure and their definition
Urgency Definition
Elective Elective procedure for stable angina pectoris
Urgent Procedure indicated by medical factors which require
the patient to stay in hospital to have operation
before discharge
Emergency Procedure performed before the beginning of the
next working day after decision to operate.
This is further subdivided in four classes:
Emergency
class 1
Persistent angina, ECG changes and/or increasing
levels of cardiac enzymes despite best medical
treatment (nitrates infusion, etc.). No need of
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sified in different stages as listed in Table 2.
Dialysis
Peritoneal or hemo-dialysis before surgery.
Functioning renal transplantation
Previous renal transplantation with preserved renal
function.
Chronic lung disease
Any long term use of bronchodilators or steroids for
lung disease.
Atrial fibrillation
Paroxysmal or persistent/permanent atrial fibrillation be-
fore surgery.
NYHA functional classes
These are defined according to the criteria listed in
Table 3 [9].
Canadian Cardiovascular Society (CCS) class 4
Inability to perform any activity without angina or an-
gina at rest, i.e., severe limitation.
Left ventricular function
Left ventricular ejection fraction recently before CABG
(in any case before anesthesia induction).
Mitral valve regurgitation
Severity of mitral valve regurgitation before CABG
graded in classes from 0 to IV.
Systolic pulmonary pressure
Systolic pulmonary pressure measured invasively before
anesthesia induction. In case a thermodilution catheter
is not inserted, systolic pulmonary pressure will be esti-
mated at echocardiography.
Coronary syndrome
Coronary syndrome refers to any of these conditions
leading to the present hospital admission for CABG: 1)
stable angina, 2) unstable angina requiring or notTable 2 Stages of renal failure
Stages eGFR level (mL/min/1.73 m2)
1 90 or above
2 89 to 60
3a 59 to 45
3b 44 to 30
4 29 to 15
5 Less than 15 or on dialysisnitrates infusion, 3) non-ST elevation myocardial infarc-
tion, 4) ST-elevation myocardial infarction.
Urgency of the procedure
This will be graded according to the criteria listed in
Table 4.
Ventricular arrhythmia
Ventricular tachycardia, ventricular fibrillation or asys-
tole requiring this hospital admission or during hospital
stay before CABG.
Out-of-hospital cardiac arrest
Cardiac arrest occurred out of the hospital and requiring
the present hospital admission for CABG.
Critical preoperative status
Ventricular tachycardia or ventricular fibrillation or
aborted sudden death, preoperative cardiac massage,inotropes
Emergency
class 2
Hemodynamic instability responsive to inotropes
Emergency
class 3
Hemodynamic instability unresponsive to inotropes
and/or requiring preoperative insertion of IABP
Emergency
class 4
Salvage CABG: patients requiring cardiopulmonary
resuscitation (external cardiac massage) en route to
the operating theatre or prior to induction of anesthesia.
This does not include cardiopulmonary resuscitation
following induction of anesthesia
Table 6 CSHA Clinical Frailty Scale
Category Definition
1 Very fit — robust, active, energetic, well-motivated and fit;
these people commonly exercise regularly and are in the
most fit group for their age
2 Well — without active disease, but less fit than people in
category 1
3 Well, with treated comorbid disease — disease symptoms
are well controlled compared with those in category 4
4 Apparently vulnerable — although not frankly dependent,
these people commonly complain of being “slowed up” or
have disease symptoms
5 Mildly frail — with limited dependence on others for
instrumental activities of daily living
6 Moderately frail — help is needed with both instrumental and
non-instrumental activities of daily living
7 Severely frail — completely dependent on others for
the activities of daily living, or terminally ill
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tive inotropes or IABP, preoperative acute renal failure
(anuria or oliguria <10 ml/hr).
Preoperative inotropic support
Preoperative use of epinephrine, norepinephrine, milri-
none, amrinone, dobutamine, dopamine, levophed and/
or levosimedan.
Preoperative use of IABP
Preoperative insertion of IABP before the start of CABG.
This refers to any IABP insertion during coronary angi-
ography, percutaneous coronary artery intervention or
in the operating room, but before skin incision.
Killip classes
These are defined according to the criteria listed in
Table 5 [10].
CSHA Clinical Frailty Scale
Preoperative patient’s frailty is graded according to the
CSHA scale as listed in Table 6 [11].
Grace score 2.0
This risk score is calculated using the on-line calculator
available at http://www.gracescore.org/WebSite/Web-
Version.aspx and reported as absolute number [12].
Syntax score
This angiographic score is calculated using the on-line
calculator available at http://www.syntaxscore.com/[13]
EuroSCORE II
This risk score is calculated using the on-line calculator
available at http://www.euroscore.org/calc.html and re-
ported in percentage. The risk factors included in the
EuroSCORE II and collected in the E-CABG registry are
defined according to the EuroSCORE II criteria [7].
Previous percutaneous coronary artery intervention
This registry included a number of variables to define ac-
curately any details on previous PCI procedures. Data on
the type of stent, either drug eluting or bare metal stents,
is collected. Titanium stents are herein considered as bareTable 5 Killip’s stages of heart failure
Stage Definition
I No clinical signs of heart failure
II Rales or crackles in the lungs, an S3, and elevated
jugular venous pressure
III Frank acute pulmonary edema.
IV Cardiogenic shock or hypotension (measured as systolic
blood pressure <90 mmHg), and evidence of peripheral
vasoconstriction (oliguria, cyanosis or sweating)metal stents. Balloon angioplasty refer to a PCI without
stenting. Attempt to PCI with failure to pass the wire/
stent through the occlusion/stenosis should not be consid-
ered as an accomplished PCI procedure. On the contrary,
any PCI attempt resulting in coronary artery complication
(thrombosis, dissection, perforation, etc.) should be con-
sidered as a prior PCI procedure. Details on PCI-related
complications are retrieved as well.Indication for CABG after PCI
The indication for CABG after any PCI procedure is de-
fined as 1) stent thrombosis, 2) in-stent restenosis and/
or 3) progression of disease.CABG after PCI
Planned CABG after PCI is defined as a staged proced-
ure in patients whose culprit lesions are treated first by
PCI and in whom coronary surgery is planned to achieve
complete myocardial revascularization immediately or
shortly after PCI. Unplanned CABG refers to any surgi-
cal revascularization after PCI which was intended to
provide definitive invasive treatment for coronary artery
disease.Number of diseased vessels
This refers to the number of vessels (one to three) with
a stenosis of at least 50 % in the main artery (the left an-
terior descending artery, the circumflex artery and the
right coronary artery) or their major branches.Left main stenosis
This is defined as any stenosis ≥50 % of the left main
trunk.
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This is defined as stenoses ≥70 % in the proximal seg-
ment of both the left anterior descending artery and the
circumflex artery.Antibiotic prophylaxis
Data on type and dose of antibiotics administered
prophylactically immediately or during surgery are
collected.Off-pump surgeon
This refers to surgeons who have operated in the pre-
ceding year at least on 20 patients using the off-pump
technique.Revascularization technique
Methods of revascularization are reported in Table 7.Epiaortic ultrasound
This refers to epiaortic ultrasound performed to investi-
gate the status of the ascending aorta.Diseased ascending aorta
This is defined as any sign of atherosclerosis in the as-
cending aorta at palpation or epiaortic ultrasound.Porcelain aorta
This is defined as an extensive circumferential calcifica-
tion of the ascending aorta.Other intraoperative data
Details of the type of grafts used, number of distal anas-
tomoses, the type of cardioplegia and its temperature as
well as the duration of aortic cross-clamping, cardiopul-
monary bypass and operation are collected.Table 7 Revascularization techniques
Technique Definition
On-pump Procedure carried out with the use
of cardiopulmonary bypass and
cardiac arrest
Off-pump Procedure carried out without the





Procedure carried out on beating
heart with the use of cardiopulmonary
bypass (without cardiac arrest)
Conversion to HB-CPB Any conversion from off-pump to
HB-CPB
Conversion to on-pump Any conversion from off-pump to
conventional surgery with the use
of cardiopulmonary bypass and cardiac arrestDrug treatment at discharge
Data on treatment with aspirin, clopidogrel, ticagrelor,
warfarin/Coumadin, low-molecular weight heparin, sta-
tins and/or ACE-inhibitors are collected.
Postoperative adverse events: definition criteria
Prolonged use of inotropics (>12 h)
This refers to the use of use of epinephrine, norepin-
ephrine, milrinone, amrinone, dobutamine, dopamine,
levophed and/or levosimedan for > 12 h after surgery.
IABP
This refers to postoperative insertion of an intra-aortic
balloon pump device.
ECMO
This refers to intra- or postoperative insertion of an
extracorporeal mechanical oxygenation device.
Resternotomy for bleeding
This refers to any reoperation for hemostasis/removal of
hematoma in presence of excessive bleeding with or
without hemodynamic problem.
Resternotomy for hemodynamic problems
This refers to any reoperation for hemodynamic prob-
lems. This can be associated also with excessive bleed-
ing: in such a case, both categories (Resternotomy for
bleeding and Resternotomy for hemodynamic problems)
are marked.
Sternal and leg wound infections
Wound complications are graded according to the Cen-
ters for Disease Control and Prevention definitions of
surgical site infections [14]. Any sternal or leg wound in-
fection occurring within three months after surgery will
be considered as postoperative wound infections.
Postoperative atrial fibrillation
It refers to any event of atrial fibrillation/flutter occurred
after CABG and detected at ECG, requiring or not
pharmacological/electrical cardioversion. Postoperative
atrial fibrillation is defined paroxysmal if it is not de-
tected at patient’s discharge. Otherwise atrial fibrillation
is defined as permanent.
Postoperative stroke
This complication is defined as any focal or global
neurological syndrome occurring during the in-hospital
stay caused by ischemia and/or hemorrhage not resolv-
ing within 24 h. The diagnosis and nature of stroke is
made on the basis of findings at computed tomography
and/or magnetic resonance imaging of the brain and
confirmed by a neurologist. When neurological signs
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fined temporary, otherwise it is defined as permanent.
Type 5 myocardial infarction
This adverse event is defined according to the recent
definition criteria by Moussa et al. [15] as summarized
in Table 8.
Delirium requiring drug treatment
Any postoperative neuropsychological syndrome requir-
ing oral or intravenous drug treatment.
Blood loss 12 h after surgery
It refers to the amount of postoperative blood losses
from mediastinal drainages within 12 h of surgery. Intra-
operative blood losses are not taken in to account.
Hemoglobin nadir during the operation day
It refers to the lowest level of hemoglobin detected on
the day of operation.
Hematocrit nadir during the operation day
It refers to the lowest level of hematocrit detected on
the day of operation.
Highest postoperative creatinine level
It refers to the highest level of serum creatinine detected
after surgery during the in-hospital stay.
Acute kidney injury
This end-point is defined as an increase in serum cre-
atinine 1.5 -1.9 times the baseline level or serum creatin-
ine increase≥26.5 μmol/l within seven days after surgery.
This definition is according to the KIDGO criteria [16],
but it considers only the change of postoperative serum
levels of creatinine as outcome end-point. Therefore,
acute kidney injury will be classified as listed in Table 9.
The need of renal replacement therapy is defined as
temporary or permanent (in case the patient dies or is
discharged on renal replacement therapy).Table 8 Definition criteria of type V myocardial infarction
Baseline condition Definition




48 h of the p
new patholog
2. In patients with elevated baseline CK-MB
(or cTn) in whom the biomarker levels are stable or falling
The CK-MB (or
above from th
3. In patients with elevated CK-MB (or cTn) in whom the
biomarker levels have not been shown to be stable or falling
The CK-MB (or
above plus ne
relevant MI, suRed blood cell (RBC) units transfused intraoperatively
It refers to the amount of RBC units transfused intraop-
eratively (before the time “at chest closure”, see below).
This does not refer to RBC units transfused before sur-
gery or after the end of surgery.
RBC units transfused perioperatively
It refers to the overall amount of RBC units intra- and/
or postoperatively transfused since the operation has
started and till the day the patient is discharged home or
to any other institution, i.e. intraoperative and postoper-
ative. This does not refer to red blood cell transfused be-
fore surgery.
Use of fresh frozen plasma, solvent/detergent treated,
pooled human plasma (Octaplas), platelets, rFVIIa,
cryo-precipitate, fibrinogen and prothrombin complex
concentrate
This refers to the use of these blood products used at
the time of chest closure as well as after the operation
until the day of discharge from the hospital. The amount
of blood products are reported in homogenous units.
Severity of postoperative bleeding
This will be graded according to the Universal Defin-
ition of Perioperative Bleeding (UDPB) in adult cardiac
surgery [17]. Severe bleeding is defined as UDPB classes
3–4. Because of the complexity of this grading system,
the E-CABG study group has developed its own grad-
ing system for a simple definition of severity of
perioperative bleeding. The E-CABG investigators rec-
ognized that the amount of postoperative blood losses
12 h after surgery as defined by the UDPB criteria may
not take into account the amount of intraoperative and
postoperative bleeding occurring later on after surgery.
Therefore the E-CABG investigators proposed a simple
classification of perioperative bleeding based on the
amount of RBC, platelets, fresh frozen/Octaplas units
transfused during the intraoperative and postoperative
period until the discharge. The methods adopted to strat-
ify this outcome end-point are described in details in theMB measured within 48 h of the procedure rises to ≥10 × the local
per limit of normal (ULN), or to ≥5 × ULN with new pathologic Q-
contiguous leads or new persistent LBBB, OR in the absence of CK-
ents and a normal baseline cTn, a cTn (I or T) level measured within
rocedure rises to ≥70 × the local laboratory ULN, or ≥35 × ULN with
ic Q-waves in ≥2 contiguous leads or new persistent LBBB.
cTn) rises by an absolute increment equal to those levels recommended
e most recent pre-procedure level.
cTn) rises by an absolute increment equal to those levels recommended
w ST-segment elevation or depression plus signs consistent with a clinically
ch as new onset or worsening heart failure or sustained hypotension.
Table 9 Grading of the severity of postoperative acute kidney injury
Stages Definition
1 1.5–1.9 times baseline
OR
Serum creatinine increase ≥26.5 μmol/l
2 Serum creatinine 2.0–2.9 times baseline
3 Serum creatinine ≥3.0 times baseline
OR
Serum creatinine increase ≥353.6 μmol/l
OR
Initiation of renal replacement therapy
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Early repeated revascularization
This refers to any CABG and/or PCI performed during
the same hospital stay for any graft and/or stent-related
complication as well as for progression of coronary ar-
tery disease.
Gastrointestinal complications
This refers to any gastrointestinal complication requiring
endoscopy and/or surgical treatment.
Length of stay in the intensive care unit
This refers to the number of days the patient was treated
in the intensive care unit (ICU) after surgery. Readmission
to ICU is also taken in to account in the estimation of
ICU stay.
Length of in-hospital stay
This refers to the number of days the patient was treated
from the day of operation till the day of discharge from
the hospital to any rehabilitation unit or home.
In-hospital death
It refers to any death occurred in during the same hos-
pital stay in the Institution where CABG was performed.
Late death
This refers to death occurring after discharge due to any
cause. Specific causes of death are collected to better de-
fine whether death is related to any cardiovascular cause.
Late stroke
This refers to any focal or global neurological syndrome
occurring after discharge and caused by ischemia and/or
hemorrhage not resolving within 24 h. The diagnosis
and nature of stroke is made on the basis of findings at
computed tomography and/or magnetic resonance im-
aging of the brain and confirmed by a neurologist.Late myocardial infarction
This refers to any myocardial infarction occurring after
discharge and requiring medical or revascularization
treatment. Since the current definition of type V myo-
cardial infarction requires adequate validation, only
myocardial infarction occurring after discharge will be
considered as late myocardial infarction.
Late repeated revascularization
This refers to any CABG and/or PCI performed after
discharge for graft and/or stent-related complication as
well as for progression of coronary artery disease.
Combined outcome end-point
This refers to any of the main outcome end-point
(all-cause mortality, stroke, myocardial infarction and/or
repeat revascularization) occurring any time after CABG.
Since the current definition of type V myocardial infarc-
tion requires adequate validation, only myocardial in-
farction occurring after discharge will be considered in
this end-point.
Classification of the severity of postoperative
complications occurring immediately after surgery
Adult cardiac surgery is associated with significant im-
mediate postoperative mortality. Indeed, early mortality
is generally considered a hard outcome end-point, and
often the only one, of any analysis evaluating the out-
come of cardiac surgery. However, the incidence of non-
fatal complications after major surgery is rather high
and may have a negative impact on patient’s recovery
and the burden of resources necessary to treat such
complications. Furthermore, postoperative complications
may have a significant impact also on late survival
[18–20].
The need of a grading system of postoperative com-
plications has been recognized in surgery as a measure
and a means to improve the quality of health care de-
livery [21]. Therefore valuable ranking systems have
been developed for the assessment of quality of surgi-
cal treatment as well as a reproducible tool in clinical
research [21, 22]. However, the existing ranking sys-
tems are more suitable for patients undergoing non-
cardiac surgery as they take into account minor
complications which are very frequent in patients
undergoing adult cardiac experience and which can be
considered of minor prognostic importance in this
subset of patients. Therefore, any method for grading
the severity and prognostic implications of postopera-
tive complications should be specifically tailored for
adult cardiac surgery.
There are objective difficulties in ranking the post-
operative complications after cardiac surgery as they
may be related to a number of preoperative risk
Table 10 Mean, median and interquartile range of score
assigned by 24 cardiac surgeons to 25 significant postoperative









Transfusion of 1 unit of RBC 0.5 0.5 1.0
Transfusion of 2–4 units of RBC 2.7 2.5 1.0
Transfusion of 5–10 units of RBC 5.2 5.0 2.0
Transfusion of > 10 units of RBC 7.2 7.0 1.0
Reoperation for bleeding 4.6 5.0 1.75
Transfusion of platelets 2.7 2.0 1.75
Transfusion of fresh frozen plasma or
Octaplas
2.7 3.0 1.75
Pericardial effusion requiring pericardial
fenestration
3.9 4.0 1.0
Postoperative use of antibiotics 1.9 2.0 1.0
Atrial fibrillation 2.3 2.0 2.0
Ventricular fibrillation/asystole 6.8 8.0 3.0
Administration of inotropics > 12 h 3.9 4.0 2.0
Acute kidney injury not requiring renal
replacement therapy
3.6 4.0 1.75
Renal failure requiring renal
replacement therapy
6.7 7.0 1.75
Deep wound infection of the leg 2.9 3.0 2.0
Deep sternal wound infection 5.0 5.0 2.75
Mediastinitis 6.6 7.0 3.75




Stroke 7.4 7.0 1.0
Postoperative IABP 5.0 5.0 2.0
Postoperative ECMO 8.6 9.0 1.0






In-hospital death 10.0 10.0 0
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portantly, relevant complications have not been thor-
oughly investigated in large clinical series. Therefore,
there is a lack of data for a proper weighting of the
prognostic impact of postoperative complications. In-
deed, previous ranking methods used in non-cardiac
surgery were not derived from statistical analyses of
clinical datasets, but rather were proposed by a few
experienced clinicians based on the current knowledge
of the clinical impact of any minor and major postop-
erative complication. A more reliable method to
stratify the clinical impact of any complications would
be to retrieve the evidence of the negative impact of
postoperative complication through meta-analytical
methods. However, data for meta-analysis could be
limited to a few major complications and may be lack-
ing for many others.
The E-CABG investigators have selected 25 complica-
tions or interventions for their treatment (Table 10),
which are believed to have a prognostic impact and
possibly associated with increased resources for their
treatment. These investigators recognized that in many
cases, an intervention performed for any complication
would provide a better stratification measure than
considering the complication itself. Because of this, a
number of complications are herein defined as any
intervention performed for their specific treatment.
These investigators decided to not enlist here some
postoperative adverse events because of intrinsic diffi-
culties in defining their true nature (for example: pneu-
monia, type V myocardial infarction, sepsis), because
they are secondary to other more significant adverse
events (for example: prolonged tracheal intubation) or
any time interval may not capture the real extent of the
event (for example: postoperative blood losses). These
investigators recognized also the difficulty in identifying
a valid definition of postoperative low-cardiac output
syndrome. In fact, thermodilution catheter is not rou-
tinely used in many centers and the use of a cutoff of
postoperative cardiac index to define this event is thus
not feasible. Furthermore, postoperative use of ino-
tropes varies significantly between institutions as their
use after cardiac surgery is not limited to the treatment
of markedly decreased cardiac index. Therefore, in this
registry the definition of postoperative severely de-
pressed cardiac function is reserved only to those con-
ditions requiring postoperative insertion of IABP or
ECMO.
Twenty-four E-CABG investigators have stratified the
prognostic and severity burden of these 25 complica-
tions or interventions for their treatment giving a score
from 0 to 10 to each of these adverse events/interven-
tions. A score of 10 was supposed to measure the worst
postoperative complication, i.e. patient’s death. Table 10summarizes the mean, median and interquartile range
of these scores.
The medians of these score were used to stratify the
prognostic importance of each complication or interven-
tion for its treatment (Table 11). Transfusion of one unit
of RBC was considered not a significant event as both its
mean and median scores were below 1. These investigators
proposed a four grades classification method of postopera-
tive complications in order to classify them according to
their increasing severity. The fourth grade includes only
the worst postoperative complication, i.e. patient’s death.
Multiorgan failure was not herein considered a postopera-
tive adverse events as this grading system includes most of
the components of this syndrome. Table 11 summarizes
Table 11 Grading and additive score for postoperative
complications or interventions for their treatment













Transfusion of platelets 2
Transfusion of fresh frozen plasma or Octaplas 3
Transfusion of 2–4 units of RBC 3
Deep wound infection of the leg 3
Permanent pace-maker implantation 3
Grade
2
Pericardial effusion requiring pericardial fenestration 4
Acute kidney injury not requiring renal replacement
therapy
4
Transfusion of 5–10 units of RBC 5
Reoperation for bleeding 5




Transfusion of > 10 units of RBC 7
Renal failure requiring renal replacement therapy 7
Mediastinitis 7
Stroke 7
Surgical or percutaneous procedure for technical
failure
7
Reoperation for hemodynamic instability 8
Ventricular fibrillation/asystole 8





Table 12 Grading and additive score for severity of intra- and
postoperative bleeding as measured by the amount of blood
products transfused and the need of reoperation for excessive
bleeding




No transfusion of blood products with the




Transfusion of platelets 2
Transfusion of fresh frozen plasma or Octaplas 3
Transfusion of 2–4 units of RBC 3
Grade
2
Transfusion of 5–10 units of RBC 5
Reoperation for bleeding 5
Grade
3
Transfusion of > 10 units of RBC 7
This classification included any transfusion of RBC, platelets, fresh frozen
plasma and Octaplas occurred during surgery and after that, during the same
in-hospital stay. Preoperative transfusions are not included in this classification
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Table 10. The sum of these scores for each complication/
intervention occurring after CABG will be used as an addi-
tive score for further stratification of the prognostic im-
portance of these events in each patient.
The E-CABG registry has been tailored to collect all
the variables for stratification of perioperative bleeding
according to the UDPB classification [17]. However, thelatter classification is rather complicated and includes a
rather large number of differed blood products for
treatment and prevention of excessive bleeding. Its use
can be limited by the inclusion in this stratification
method of the amount of blood losses. In fact, time
interval (12 h after surgery) is supposed to not capture
the real amount of bleeding occurring after cardiac sur-
gery. Therefore, extrapolating the medians of Table 10,
the E-CABG investigators propose a grading of the se-
verity of intra- and postoperative bleeding based on the
type and amount of blood products transfused during
surgery and the in-hospital stay as well as on the need
of reoperation for bleeding (Table 12). The authors
propose also an additive score to better grade the need
to treat severe intra- and postoperative bleeding.Practical implications
This multicenter, prospective registry has been planned
to investigate a number of controversial issues regarding
the prognostic impact of baseline risk factors as well as
treatment methods for surgical myocardial revasculariza-
tion. This registry will provide also data on the role of
pre- and postoperative pharmacological treatments on
the outcome of patients undergoing CABG. These infor-
mations are expected to provide further knowledge on
Biancari et al. Journal of Cardiothoracic Surgery  (2015) 10:90 Page 12 of 12the mechanisms leading to adverse events after CABG
and prevent them.
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